Allergy Capital

 

About the Author

Revised 22 December 2006

 

allergy capitalallergy asthma information for patientsallergy asthma information for health professionalsallergy asthma information for patientsallergy asthma practice

 


Dr Raymond Mullins is an Australian consultant physician practicing in the specialty of clinical immunology and allergy. He graduated from the University of Sydney in 1982, and trained in clinical immunology and allergy at Royal Prince Alfred Hospital in Sydney. He was admitted to Fellowship of the Royal Australasian College of Physicians and Royal College of Pathologists of Australalasia in 1989.

He completed a PhD in immunology of at the Centenary Institute for Cancer Medicine and Cell Biology in Sydney in 1991. He was appointed staff specialist in Clinical Immunology at the Royal Newcastle Hospital in the same year.

In 1992 he was granted a Neil Hamilton Fairley NHMRC Post-Doctoral Research Fellowship which was undertaken at the Kennedy Institute of Rheumatology & Charing Cross Hospital in London.He returned to Sydney in 1994 and moved to Canberra in 1995.He practices as a consultant physician in clinical immunology and allergy.

He currently has appointments as Clinical Senior Lecturer in Medicine (Canberra Clinical School), University of Sydney, Clinical Senior Lecturer in Medicine (Medical School), Australian National University and Adjunct Associate Professor, Clinical Immunology, University of Canberra.

Clinical interests include the management of asthma and hay fever, anaphylaxis, allergic reactions to food, medication and insect stings, food intolerance, sinus disease and immune deficiency.

Current research interests include the cause and epidemiology of anaphylaxis and its rate of relapse, gelatin (gelatine) allergy as a non-obvious trigger for anaphylaxis, and anaphylactic reactions to Australian venomous ants ("Jumper Ants").

Current Research Grants: NHMRC Australia 3 year Project Grant 404050 to commence 2006 (Co-investigator): Life-threatening allergy (anaphylaxis) to Australian ant venoms. A/Prof Simon Brown, Dr Robert Heddle. Mr Michael Wiese, Dr Richard Loh, A/Prof Raymond Mullins.

He belongs to the following professional societies:

He has filled various committee roles in the Australasian Society for Clinical Immunology and Allergy including as Newsletter Editor and Chair of the Clinical and Laboratory Practice Committee. He has chaired the Education Committee 2000-2006 involved in generating patient educational material for the ASCIA web site. He acts as a medical advisor for Anaphylaxis Australia (previously known as FACTS) and is series co-editor foe the Mecical Journal of Australia "Allergy Update" series published 2006.


PUBLICATIONS

Brown MA, Mullins RJ, Stokes GS, Gyory A.Z. Essential hypernatraemia: Disordered thirst and blood pressure control. Aust NZ J Med. 1985. 15:751-754.

Mullins RJ. Yersinnia arthritis. Aust NZ J.Med. 1986. 16:83.

Mullins RJ, Bastion B, Sutherland DC. AIDS and the heart. Aust NZ J Med. 1988. 18:809-811.

Mullins RJ, Olson LG, Sutherland DC. Nasal histamine challenges in normal and allergic subjects. J Allergy Clin Immunol. 1989. 83: 955-959.

Mullins RJ, Basten A. The effect of preincubation of cells in serum on the response to antigen in leprosy patients and healthy controls. Int J Leprosy. 1989. 57:777 - 787.

Fournie J-J, Adams E, Mullins RJ, Basten A. Inhibition of T lymphocyte proliferation by mycobacterial phenolic glycolipids in humans. Infect Immun. 1989. 57:3-9.

Fournie J-J, Mullins RJ, Basten A. A monoclonal antibody defined phospholipidic antigen from Mycobacterium leprae: Characterisation, purification and use for diagnosis of M.leprae exposure. J Biol Chem. 1991. 266:1211-1219.

Mullins RJ, Fournie J-J, Maloney B, Brown P, Jones P, Basten A. Serological response to mycobacterial phosphatidyl inositol mannosides in healthy controls and patients with leprosy and tuberculosis. Int J Leprosy . 1992. 60:353-367.

Mullins RJ, Russell A McGrath GJ, Smith R, Sutherland DC. Breast feeding anaphylaxis. Lancet. 1992. 338:1279-1280.

Mullins RJ, Roche P, Adams E, Jones P, Chen S, Theuvenet W, Basten A. Limiting dilution analysis in leprosy. Imm Cell Biol. 1992.70:277-290.

Feldmann M, Dayan C, Quarantino S, Mullins R, Londei M. Mechanisms involved in the pathogenesis of thyroiditis: usefulness of T cell cloning to define antigens, epitopes and the role of anergy in disease induction in: 80 Years of Hashimoto Disease. Nagataki S, Mori T and Torizuka K (eds) Exerpta Medica International Congress Series 1028 (Proceedings of the International Hashimoto's Symposium, December 2-5, 1992. Fukuoka, Japan). 1993. Elselvier Science Publishers, Amsterdam, The Netherlands.

Baumgart KW, Britton W, Mullins RJ, Basten A, Barnetson R StC. Subclinical infection with M leprae - a problem for leprosy control strategies. Trans Royal Soc Trop Med Hygeine. 1993.87:412-415.

Mullins RJ, Chernajovsky Y, Dayan C, Feldmann M. Transfection of thyroid autoantigen into autologous antigen-presenting cells in patients with Graves' disease (abstract). J Endocrinol Invest. 1993.16 (supplement 2):118

Mullins RJ, Chernajovsky Y, Dayan C, Londei M, Feldmann M. Transfection of thyroid autoantigens into EBV lines; recognition by Graves' disease thyroid T cells. J Immunology 1994. 152:5572-5580.

Mullins RJ, Cohen S, Webb L, Chernajovsky Y, Dayan C, Londei M, Feldmann M. Heterogeneity of cytokine release by human TSH receptor-specific T cell clones; identification using autoantigen-transfected EBV-transformed B cell lines in Graves' disease. J Clin Invest. 1995. 96:30-37.

Mullins RJ. Dental implications of drug allergy. Aust Prescr. 1995. 18:7.

Mullins RJ, Walker T. Allergic reactions to oral, surgical and topical bovine collagen: anaphylactic risk for surgeons. Aust NZ J Opthal 1996; 24: 257-260.

Mullins RJ, Shanahan TM and Dobson RT. ACE inhibitor induced visceral angioedema. Med J Aust 1996; 165: 319-321.

Mullins RJ. ACE inhibitor induced visceral angioedema. Internet-based computer-interactive teaching case formatted by Med-E-Serve Internet provider, Queensland. Prepared for the Annual Scientific Meeting of the Royal Australasian College of Physicians, Canberra, May 1996. URL http://www.medeserv.com.au/rmullins/users/intro.html

Mullins RJ. Images in Medicine: "Allergic " reactions to xylocaine. Med J Aust 1997; 167: 23.

Mullins RJ. Autoimmune thyroid disease. Aust NZ J Med 1997; 27: 78-9.

Mullins RJ. Echinacea associated anaphylaxis. Med J Aust 1998; 168: 170-1.

Mullins RJ. Investigation of Urticaria. Modern Medicine 1998; 41: 119-124.

Mullins RJ. Echinacea associated anaphylaxis (reply to comment). Med J Aust 1998; 168:583-4.

Mullins RJ. How to investigate the patient with urticaria. Modern Medicine of South Africa. Sept 1999: 48-54.

Mullins RJ. Allergic reactions to Echinacea. J Allergy Clin Immunol 2000; 105 (1 part 2): S268-9.

Baumgart K, Mullins RJ. Use of hydroxychloroquine in refractory urticaria. J Allergy Clin Immunol 2000; 105 (1 part 2):S340-1.

Mullins RJ. Anaphylaxis in Australia's Capital - I: Incidence and Relapse. ACI International 2000 (Supplement 2); 98.


Mullins RJ. Anaphylaxis in Australia's Capital - II: Clinical Features. ACI International 2000 (Supplement 2); 98.

A-L Ponsonby, Glasgow N, Gatenby P, Mullins R, McDonald T, Hurwitz M, Pradith B, Attewell R. The relationship between low level nitrogen dioxide exposure and child lung function after cold air challenge. Clin Exp Allergy 2001; 31: 1205-1212.


Mullins RJ, Heddle R. Adverse Reactions Associated with Echinacea: The Australian Experience. Ann Allergy Asthma Immunol 2002; 88: 42-51.


Mullins RJ. Anaphylaxis: Diagnosis and Management. Current Therapeutics. 2002. February 2002: 59-65.

Mullins RJ. Anaphylaxis. N Ethical J 2002; 5 (3): 43-50

Ponsonby A-L, Gatenby P, Glasgow N, Mullins R, McDonald T, Hurwitz M. Which clinical subgroups within the spectrum of child asthma are attributable to atopy? An epidemiological assessment. Chest 2002: 121:135-142.

Ponsonby A-L, Gatenby P, Glasgow N, Mullins R, Hurwitz M, McDonald T. The association between synthetic bedding and adverse respiratory outcomes among skin-prick test positive and skin-prick test negative children. Allergy 2002; 57: 247-53.

Healthy Homes. A guide to indoor air quality in the home for buyers, builders and renovators. Commonwealth Department of Health and Aging, Canberra, Australia 2003.

Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 2003; 33: 1033-40.

Mullins RJA, Apostolou E. Anaphylaxis to beef, gelatin and Haemaccel. (Downloadable Conference Poster pdf). J Allergy Clin Immunol 2004; 113 (2, abstract 861): S241.

Mullins RJ, Heddle R. Adverse reactions associated with echinacea and other Asteraceae in: S.C. Miller and H. Yu (eds). ECHINACEA: The genus Echinacea" a volume in the series entitled: "MEDICINAL AND AROMATIC PLANTS ­ INDUSTRIAL PROFILES", Harwood Academic Publishing - Taylor & Francis Books Ltd., London, UK 2004. ISBN 0-415-28828-2.

Mullins RJ, Lones R, Dutta B. Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops.
Australas J Dermatol. 2004 May;45(2):151-2.

K Baumgart, S Brown, M Gold, A Kemp, R Loblay, R Loh, D Mitrou, R Mullins, J Peake, J Ruhno, M Said, J Sinclair, V Smith, W Smith, G Solley, V Soutter, M Tang, J Ziegler. ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child-care centres. J Paed Child Health 2004; 40: 669.

Mullins RJ et al. ASCIA Position Statement: Unorthodox Techniques for the Diagnosis and Treatment of Allergy, Asthma and Immune Disorders. October 2004.


Co-author of professional and consumer publications written by the National Asthma Campaign and Australasian Society for Clinical Immunology and Allergy: Asthma and Allergy, and Asthma and Complementary Therapies Commonwealth Department of Health and Aging (2005). http://www.nationalasthma.org.au/HTML/management/info_papers/index.asp

Mullins RJ, Heddle R. Echinacea in the prevention and treatment of infections. Medicine Today 2005; 6: 79-81.


Mullins, Heddle R, Smith P. Non conventional approaches to allergy testing: reconciling patient autonomy with medical practitioners' concerns. Med J Aust 2005; 183:173-4.

Mullins RJ. Systemic allergy to topical hexamidine. Med J Aust 2006; 185: 177.

Co-author of Asthma Management Handbook 2006 (Complementary Medicine chapter).

Kemp A, Mullins RJ, Weiner JM. The allergy epidemic - what is the Australian response? (Editorial). Med J Aust 2006; 185: 226-7.

Brown SGA, Mullins RJ, Gold MS. Anaphylaxis: Diagnosis and Management. Med J Aust 2006; 185: 283-289.


Mullins RJ. Time trends for food allergy 1995-2006 in the ACT: increased incidence or increased anxiety? Internal Medicine J 2006; 36 (Suppl. 6): A208, P29.